Cystic fibrosis drug reduces hospital visits and offers patients hope – at a cost
New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a ...
Saskatchewan expands Trikafta coverage for cystic fibrosis
The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and ...
Leader Post on MSN3 天
Cystic fibrosis drug now available to more people in Saskatchewan
The change comes in light of a recommendation made earlier this month by the Canadian Agency for Drugs and Technologies in ...
westcentralonline2 天
Saskatchewan expands access to life-changing cystic fibrosis drug
More cystic fibrosis (CF) patients in Saskatchewan now have access to Trikafta, a groundbreaking medication that improves ...
Spirovant Sciences achieves milestone for experimental cystic fibrosis treatment
The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...
discovermoosejaw20 小时
Province expands Trikafta access for Cystic Fibrosis patients
The provincial government announced Monday that more cystic fibrosis (CF) patients in Saskatchewan are now eligible for ...
STAT2 天
The health care system is ill-equipped to recognize and treat cystic fibrosis in non-white ...
Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.
Tiverton mum takes on marathon for cystic fibrosis awareness
Lauren Butler, inspired by her daughter’s battle with cystic fibrosis, takes on the London Marathon to raise funds and ...
Daily Express20 天
Cystic fibrosis wonder drug raises life expectancy of sufferers by 8 years
Cystic fibrosis sufferers' average life expectancy has soared from 56 to 64 in just two years, thanks to wonder drugs the Daily Express helped secure on the NHS. After our campaign, NHS England ...
Daily Express18 天
Cystic fibrosis wonder drug dramatically raises patients' life expectancy by 8 years
Newborn Cystic fibrosis sufferers' average predicted life expectancy has soared from 56 to 64 in just two years, thanks to wonder drugs the Daily Express helped secure on the NHS. After our ...
Yahoo Finance10 天
Non-Cystic Fibrosis Bronchiectasis Pipeline Insight: Over 15 Companies are Progressing ...
DelveInsight’s 'Non-Cystic Fibrosis Bronchiectasis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline non-cystic fibrosis bronchiectasis therapies in various stages of ...